Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2702-2709

  Boughey, Judy C ^a   Hoskin, Tanya L ^b   Degnim, Amy C ^a   Sellers, Thomas A ^c   Johnson, Joanne L ^a   Kasner, Melanie J ^a   Hartmann, Lynn C ^a   Frost, Marlene H ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

^b Mayo Clinic   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTRALATERAL PROPHYLACTIC MASTECTOMY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 78049470319     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1136-7     Document Type: Article

References (25)

1. TM Tuttle EB Habermann EH Grund, et al. 2007 Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment J Clin Oncol 25 5203 5209 10.1200/JCO.2007.12.3141 17954711
2. TM Tuttle S Jarosek EB Habermann, et al. 2009 Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 1362 1367 10.1200/JCO.2008.20.1681 19224844
3. SK McDonnell DJ Schaid JL Myers, et al. 2001 Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer J Clin Oncol 19 3938 3943 1:STN:280:DC%2BD3Mrjt1Cgsg%3D%3D 11579114
4. TR Rebbeck T Friebel HT Lynch, et al. 2004 Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 22 1055 1062 10.1200/JCO.2004.04.188 14981104
5. EA Peralta JD Ellenhorn LD Wagman, et al. 2000 Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer Am J Surg 180 439 445 1:STN:280:DC%2BD3M7lvVWqsQ%3D%3D 10.1016/S0002-9610(00)00505-5 11182394
6. LJ Herrinton WE Barlow O Yu, et al. 2005 Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project J Clin Oncol 23 4275 4286 10.1200/JCO.2005.10.080 15795415
7. TC van Sprundel MK Schmidt MA Rookus, et al. 2005 Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers Br J Cancer 93 287 292 10.1038/sj.bjc.6602703 16052221
8. N Hoogerbrugge P Bult LM de Widt-Levert, et al. 2003 High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer J Clin Oncol 21 41 45 1:STN:280: DC%2BD38jktF2jtA%3D%3D 10.1200/JCO.2003.02.137 12506168
9. K Leunen M Drijkoningen P Neven, et al. 2008 Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Breast Cancer Res Treat 107 79 86 10.1007/s10549-007-9525-8 17431765
10. KD Graves BN Peshkin CH Halbert, et al. 2007 Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors Breast Cancer Res Treat 104 321 329 10.1007/s10549-006-9423-5 17066320
11. K Goldflam KK Hunt JE Gershenwald, et al. 2004 Contralateral prophylactic mastectomy. Predictors of significant histologic findings Cancer 101 1977 1986 10.1002/cncr.20617 15389473
12. VR Pennisi A Capozzi 1989 Subcutaneous mastectomy data: a final statistical analysis of 1500 patients Aesthet Plast Surg 13 15 21 1:STN:280:DyaL1M3ntVSgsA%3D%3D 10.1007/BF01570320
13. AE Giuliano S Boolbol A Degnim, et al. 2007 Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 Ann Surg Oncol 14 2425 2427 10.1245/s10434-007-9447-z 17597344
14. Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004;4:CD002748.
15. CT Brekelmans C Seynaeve M Menke-Pluymers, et al. 2006 Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 17 391 400 1:STN:280:DC%2BD287ht1OksQ%3D%3D 10.1093/annonc/mdj095 16322115
16. CT Brekelmans MM Tilanus-Linthorst C Seynaeve, et al. 2007 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 867 876 1:CAS:528:DC%2BD2sXisleitLw%3D 10.1016/j.ejca.2006.12.009 17307353
17. I Bedrosian CY Hu GJ Chang 2010 Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients J Natl Cancer Inst 102 401 409 10.1093/jnci/djq018 20185801
18. Bergstralh EJ, Kosanke JL. Computerized matching of cases to controls. Tech Rep. 1995;56.
19. JC Boughey N Khakpour F Meric-Bernstam, et al. 2006 Selective use of sentinel lymph node surgery during prophylactic mastectomy Cancer 107 1440 1447 10.1002/cncr.22176 16955504
20. E Chabner A Nixon R Gelman, et al. 1998 Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer J Clin Oncol 16 2045 2051 1:STN:280: DyaK1c3ovFCnsA%3D%3D 9626202
21. P Broet A de la Rochefordiere SM Scholl, et al. 1995 Contralateral breast cancer: annual incidence and risk parameters J Clin Oncol 13 1578 1583 1:STN:280:DyaK2MzisFyksQ%3D%3D 7602346
22. G Quan SJ Pommier RF Pommier 2008 Incidence and outcomes of contralateral breast cancers Am J Surg 195 645 650 10.1016/j.amjsurg.2008.01.007 18424281
23. MH Frost JM Slezak NV Tran, et al. 2005 Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance J Clin Oncol 23 7849 7856 10.1200/JCO.2005.09.233 16204003
24. SM Zion JM Slezak TA Sellers, et al. 2003 Reoperations after prophylactic mastectomy with or without implant reconstruction Cancer 98 2152 2160 10.1002/cncr.11757 14601084
25. Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet. 2000;356(9245):1876-81.